コンテンツへスキップ
Merck

C7118

Sigma-Aldrich

セフジニル

≥97.0% (HPLC)

別名:

syn-7-[2-(2-アミノ-4-チアゾリル)-2-ヒドロキシイミノアセトアミド]-3-ビニル-3-セフェム-4-カルボン酸, BMY-28488, FK-482, [6R-[6α-7β(Z)]]-7-[[(2-アミノ-4-チアゾリル)(ヒドロキシイミノ)アセチル]アミノ]-3-エテニル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクト-2-エン-2-カルボン酸

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
C14H13N5O5S2
CAS番号:
分子量:
395.41
UNSPSCコード:
51101500
NACRES:
NA.85

品質水準

アッセイ

≥97.0% (HPLC)

形状

powder or crystals

pKa 

9.70

mp

170 °C

抗生物質活性スペクトル

Gram-negative bacteria
Gram-positive bacteria

作用機序

cell wall synthesis | interferes

保管温度

room temp

InChI

1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1

InChI Key

RTXOFQZKPXMALH-GHXIOONMSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

Chemical structure: ß-lactam

アプリケーション

Cefdinir was used to study bacterial infections caused by Staphylococcus aureus and Neisseria gonorrhoeae and the horizontal transfer of the ftsI gene in H. influenzae.
次世代のセファロスポリン系抗生物質グラム陽性菌およびグラム陰性菌に対し、バランスのとれた優れた抗菌作用を示します。

生物化学的/生理学的作用

Cefdinir is an advanced generation amino-2-thiazolyl cephalosporin effective against Gram-positive and Gram-negative bacteria. It acts by disrupting the synthesis of the peptidoglycan layer of bacterial cell walls. It is also known to inhibit human neutrophil myeloperoxidases.

その他情報

Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

保管分類コード

11 - Combustible Solids

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

この製品を見ている人はこちらもチェック

Janet R Casey et al.
Drugs, 72(15), 1991-1997 (2012-10-09)
10 days of amoxicillin/clavulanic acid high dose and 5 days of cefdinir have been the preferred first- or second-line antibiotics for treatment of children with acute otitis media (AOM) since 2004, as recommended by the American Academy of Pediatrics in
Indi Trehan et al.
The New England journal of medicine, 368(5), 425-435 (2013-02-01)
Severe acute malnutrition contributes to 1 million deaths among children annually. Adding routine antibiotic agents to nutritional therapy may increase recovery rates and decrease mortality among children with severe acute malnutrition treated in the community. In this randomized, double-blind, placebo-controlled
M T Labro et al.
Journal of immunology (Baltimore, Md. : 1950), 152(5), 2447-2455 (1994-03-01)
Cefdinir, a new oral 2-amino-5-thiazolyl cephalosporin, inhibited the luminol-amplified chemiluminescence (LACL) response of human neutrophils stimulated by PMA but not opsonized zymosan, in a concentration-dependent but not time-dependent manner. The LACL response to opsonized zymosan in cytochalasin B-treated neutrophils was
Helio S Sader et al.
Expert review of anti-infective therapy, 5(1), 29-43 (2007-02-03)
Cefdinir is an oral third-generation cephalosporin (also known as an advanced-spectrum or generation cephem) with good in vitro activity against the pathogens responsible for community-acquired respiratory tract infections and uncomplicated skin and skin structure infections. The drug distributes very well
D R Guay
The Pediatric infectious disease journal, 19(12 Suppl), S141-S146 (2001-01-06)
Oral second and third generation cephalosporins are undergoing continuing research and development in the arena of pediatric infectious disease in an attempt to fill voids created by existing agents in the quest for the "ideal" antimicrobial. This paper reviews the

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)